Clinical Scorecard: The Role of GLI3 in Cancer: A Context-Sensitive Regulator with Potential for Diagnosis, Prognosis, and Treatment
At a Glance
Category
Detail
Condition
Cancer
Key Mechanisms
GLI3 functions as a transcription factor in the Hedgehog signaling pathway, exhibiting both oncogenic and tumor-suppressive effects depending on context.
Target Population
Patients with various malignant tumors.
Care Setting
Oncology and precision medicine.
Key Highlights
GLI3 isoforms (GLI3A and GLI3R) play critical roles in tumor biology.
Dysregulated GLI3 signaling is linked to cancer stem cell maintenance and therapeutic resistance.
GLI3 expression patterns may serve as diagnostic and prognostic biomarkers.
Emerging therapies target GLI3 through various modulation strategies.
Guideline-Based Recommendations
Diagnosis
Assess GLI3 expression and isoform patterns for potential diagnostic utility.
Management
Consider GLI3 as a therapeutic target in precision oncology approaches.
Monitoring & Follow-up
Monitor GLI3 signaling alterations for implications in treatment response.
Risks
Dysregulation of GLI3 may contribute to tumor progression and therapeutic resistance.
Patient & Prescribing Data
Individuals diagnosed with various cancers exhibiting altered GLI3 signaling.
Therapeutic strategies may involve indirect modulation or direct inhibition of GLI3.
Clinical Best Practices
Develop isoform-specific detection methods for GLI3.
